Predictive Oncology Inc (POAI) Actualités

Form 8-K - Current report

Form 425 - Prospectuses and communications, business combinations

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Company Commits the First Tranche of Financing to Initiate the Integration of AI/ML Platform Technologies, Core...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Investors Eye Biotech Sector as Cancer Therapy Market Surges

Investors Eye Biotech Sector as Cancer Therapy Market Surges PR Newswire VANCOUVER, BC, Feb. 19, 2025 USA News...

Investors Eye Biotech Sector as Cancer Therapy Market Surges

Investors Eye Biotech Sector as Cancer Therapy Market Surges PR Newswire VANCOUVER, BC, Feb. 19, 2025 USA News...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Renovaro Issues Shareholder Letter and Provides Corporate Update

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE...

Form 8-K - Current report

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens...

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]